Pharmaceutical Law & Industry Report® Table of Cases

FDA; Actavis Elizabeth LLC v. (D.C. Cir.), 1425
FDA; Amphastar Pharms. Inc. v. (D.D.C.), 1396; 1459
FDA; CareToLive v. (6th Cir.), 203
FDA; Novartis Pharms. Corp. v. (D.D.C.), 1244
FDA; Roxane Labs. Inc. v. (D.D.C.), 414
FDA; Sanofi-Aventis U.S. LLC v. (D.D.C.), 975; 1018; 1138
Federal Trade Comm'n

See FTC

Feldstein, U.S. ex rel. v. Organon Inc. (3d Cir.), 182
Ferring B.V. v. Meijer Inc. (U.S., rev den), 852
Ferring Pharms. Inc. v. River's Edge Pharms. LLC (D. Md.), 1081
F. Hoffmann-LaRoche Ltd.; Amgen Inc. v. (D. Mass.), 5
Finnicum v. Wyeth Inc. (E.D. Tex.), 588
Flemings v. Merck & Co. (2d Cir.), 1466
Flesner v. Bayer AG (8th Cir.), 354
Flonase Antitrust Litig., In re (E.D. Pa.), 124; 921
Florida v. Abbott Labs. (D. Del.), 59
Flowers v. AstraZeneca Pharms. LP (Del. Super. Ct.), 1249
Food and Commercial Workers, Local 1776 v. Eli Lilly & Co. (2d Cir.), 1217
Food and Drug Admin.

See FDA

Forest Labs. Inc. v. Lupin Pharms. Inc. (D. Del.), 7; 978
Forest Pharms. Inc.; U.S. v. (D. Mass.), 1177
Fosamax Prods. Liab. Litig., In re (S.D.N.Y.), 159; 388
Fougner v. I-Flow Corp. (D. Minn.), 890
Foust v. Wyeth (Pa. Ct. Com. Pl.), 278
Fresenius Med. Care Holdings Inc. v. Amneal Pharms. LLC (D. Mass.), 1145
Friedman v. Sebelius (D.D.C.), 161; 1575
Frisby-Cadillo v. Mylan Inc. (N.D. Cal.), 650
FTC v. Bisaro (D.D.C.), 942; 979; 1080; 1553
FTC v. Lundbeck Inc. (D. Minn.), 1176
Fulgenzi v. Wyeth Inc. (N.D. Ohio), 274
Fussman v. Novartis Pharms. Corp. (M.D.N.C.), 1400